SCHEMBL1406864

SCHEMBL1406864

COc1ccc2cc(C(=O)NNC(=O)c3ccccc3)c(=O)oc2c1C

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.63
▸ POLB P06746 3/20 0.62
▸ ALDH1A1 P00352 2/20 0.62
▸ MAOA P21397 1/20 0.61
▸ MAOB P27338 1/20 0.61
▸ RAB9A P51151 4/20 0.56
▸ NPC1 O15118 3/20 0.56
▸ HSD17B10 Q99714 1/20 0.53
▸ HPGD P15428 1/20 0.51
▸ MEN1 O00255 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ KDM4E B2RXH2 1/20 0.50
▸ CA12 O43570 1/20 0.50
▸ CA1 P00915 1/20 0.50
▸ CA2 P00918 1/20 0.50
▸ CA3 P07451 1/20 0.50
▸ CA4 P22748 1/20 0.50
▸ CA6 P23280 1/20 0.50
▸ CA5A P35218 1/20 0.50
▸ CA7 P43166 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1406414 0.81 CA12 (0.68) POLBALDH1A1MAOAMAOBHSD17B10
SCHEMBL1406862 0.80 MAOA (0.49) MAPTPOLBALDH1A1MAOAMAOB
SCHEMBL1406666 0.78 MAOA (0.49) MAPTPOLBALDH1A1MAOAMAOB
SCHEMBL5087141 0.78 MAOA (0.49) MAPTPOLBALDH1A1MAOAMAOB
SCHEMBL1406631 0.77 KDM4E (0.74) MAPTPOLBALDH1A1MAOAMAOB
SCHEMBL4522651 0.76 MAOB (0.59) MAPTMAOAMAOBRAB9AHSD17B10
SCHEMBL3881940 0.74 MAOB (0.65) MAPTPOLBMAOAMAOBRAB9A
SCHEMBL22129765 0.74 ALDH1A1 (0.59) MAPTPOLBALDH1A1MAOAMAOB
SCHEMBL12869894 0.74 MAOB (0.70) MAPTPOLBALDH1A1MAOAMAOB
SCHEMBL13345862 0.72 NPC1 (1.00) MAPTALDH1A1MAOAMAOBRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2295053-B1 Novel 2H-chromen-2-one-3-carboxamides for medical uses INST MATERIA MEDICA CAMS (CN) 2016-10-19 — — EP disclosed
US-8338401-B2 Coumarin-amide derivatives and its preparation, said drug composition and its use INSTITUTE OF MATERIA MEDICA CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2012-12-25 — — US disclosed
EP-2295053-A1 Novel 2H-chromen-2-one-3-carboxamides for medical uses THE INSTITUTE OF MATERIA MEDICA OF CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2011-03-16 — — EP disclosed
US-20060148834-A1 Novel coumarin-amide derivatives and its preparation, said drug composition and its use INSTITUTE OF MATERIA MEDICA CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2006-07-06 — — US disclosed
EP-1570846-A1 THE NOVEL COUMARIN-AMIDE DERIVATIVES AND ITS PREPARATION, SAID DRUG COMPOSITION AND ITS USE THE INSTITUTE OF MATERIA MEDICA OF CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2005-09-07 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060148834-A1 Novel coumarin-amide derivatives and its preparation, said drug composition and its use INSR, GLS, INSRR MAPT 3985/4885POLB 4137/4885ALDH1A1 1795/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback